Mammalian DEAD‐box RNA helicase DDX5, its paralog DDX17, and their orthologs in Saccharomyces cerevisiae and Drosophila melanogaster define a subfamily of DEAD‐box proteins.

Mammalian DEAD‐box RNA helicase DDX5, its paralog DDX17, and their orthologs in Saccharomyces cerevisiae and Drosophila melanogaster define a subfamily of DEAD‐box proteins.
An atypical, low‐power, atmospheric pressure plasma source for application in plasma medicine.
Primary cilia, membrane-bound organelles, are key coordinators of signaling pathways.
Carbon nanomaterials are promising therapeutic and diagnostic agents for healthcare applications including imaging and drug-delivery.
An analysis of nuclear body protein disorder that suggests MLO proteomes are significantly more disordered than structured cellular features.
Frank Caruso on nanomaterials for the future of medicine.
Joanna Aizenberg talks about the people who inspire her, her advice to early-career researchers, and her hopes for the future of scientific research.
It is a well‐known fact that RNA is the target of a plethora of modifications which currently amount to over a hundred. The vast majority of these modifications was observed in the two most abundant classes of RNA, rRNA and tRNA. With the recent advance in mapping technologies, modifications have been discovered also in mRNA and in less abundant non‐coding RNA species.
The required features of nanofactories, and current strategies for their design and fabrication.
Check out the latest covers of Advanced Healthcare Materials!